Fingerprint
Dive into the research topics of 'Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2–overexpressing breast cancer: TBCRC 006'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically